Digital Genome Market Size, Share Global Analysis Report, 2023 – 2030

Industry Insights

[201+ Pages Report] According to the report published by Facts and Factors, the global Digital Genome Market market size was valued at around USD 7.5 billion in 2022 and is predicted to grow around USD 11.50 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.30% between 2023 and 2030. The report analyses the global Digital Genome Market market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Digital Genome Market market.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the digital genome industry. The report analyzes and declares the historical and current trends analysis of the digital genome industry and subsequently recommends the projected trends anticipated to be observed in the digital genome market during the upcoming years.

The digital genome market report analyzes and notifies the industry statistics at the global as well as regional and country levels to acquire a thorough perspective of the entire digital genome market. The historical and past insights are provided for FY 2019 to FY 2021 whereas projected trends are delivered for FY 2022 to FY 2030. The quantitative and numerical data is represented in terms of value (USD 11.50 Billion) from FY 2020 – 2030.

Key Insights from Primary Research

• As per our primary respondents, the global digital genome market is set to grow annually at a rate of around 10%.
• It was established through primary research that the global digital genome market was valued at around USD 7.5 Billion in 2019.
• The “Sequencing & Analysis Software” category, on the basis of product segmentation, was the leading revenue-generating category in 2019.
• On the basis of end-user segmentation, the “Academics and Research Institutes” category was the leading revenue-generating category in 2019.
• Based on the region, North America was the leading revenue-generating category in 2019.

Key Recommendations from Analysts

• As per our analysis, the global digital genome market is growing at a high CAGR and various end-use industries are aware of this potential market and applications of the digital genome.
• Growing at a CAGR of around 10%, the global digital genome market provides numerous opportunities for all of the involved stakeholders across the entire value chain.
• Our analysts have identified sequencing & analysis software and academics and research institutes segments will be dominating for global digital genome market in terms of product and end-user segmentation respectively.
• As per our analysis, North America is expected to account for the maximum revenue share, in the target market.
• The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the digital genome industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the digital genome industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the digital genome market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the digital genome industry. The digital genome market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market positions in the digital genome sector. Vital strategic developments in the digital genome market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the digital genome market are appropriately highlighted in the report.

The digital genome market is estimated to develop with a healthy CAGR in the upcoming years. Genome Organizations have wide applications in clinical analysis and science that lead to the growth of the industry. In addition, biotech firms are substituting traditional consistency sequencing techniques for novel processes. For example, BT cotton improvement is used to give bug resistance. This advancement has had a positive impact on the applied genomics industry. Nonetheless, factors such as safety and security of patient information, lack of knowledge of advanced genomes,s, and incorrect outcomes are likely to obstruct market innovations in the coming years.

The global digital genome market has been segmented on the basis of product, end-user, and application. On the basis of product segment the target market is segmented into Sequencing Chip, Sample Preparation Instruments, Sequencing & Analyzer Instruments, DNA/ RNA Analysis Kits, and Sequencing & Analysis Software. On the basis of application segment, the global market is segmented into Transplantation, Research & Development, Reproductive & Genetic, Microbiology, Livestock & Agriculture, and Forensics. Further, the End User segment is bifurcated as Diagnostics & Forensic Labs, Hospitals, Bio-Pharmaceutical Companies, and Academics & Research Institutes.

Report Scope

Some of the essential players operating in the market are as follows: 

•  Thermo Fisher Scientific.
•  Quest Diagnostics
•  Qiagen
•  perkinelmer Inc.
•  nanostring Technologies Inc.
•  Illumina
•  Genomic Health Inc
•  GE Healthcare
•  F. Hoffmann-La Roche Ltd
•  Biomerieux
•  BD Company
•  genmark Diagnostics Inc.
•  Agilent Technologies Inc.

The taxonomy of the digital genome Market by its scope and segmentation is as follows:

By Product Segment Analysis

• Sequencing & Analyzer Instruments
• DNA/ RNA Analysis Kits
• Sequencing Chips
• Sequencing & Analysis Software
• Sample Preparation Instruments

 By Application Segment Analysis

• Microbiology
• Reproductive & Genetic
• Transplantation
• Livestock & Agriculture
• Forensics
• Research & Development

 By End User Segment Analysis

• Academics & Research Institutes
• Diagnostics & Forensic Labs
• Hospitals
• Bio-Pharmaceutical Companies

By Region Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest Of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• The Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa